Fina Biosolutions Competitors and Similar CompaniesClear all

Novartis's competitors and similar companies include Moderna and Regeneron Pharmaceuticals.

	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.	Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Founding Date	Founding Date 1996	Founding Date 2010	Founding Date 1988
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more	Locations Cambridge, US HQ Melbourne, AU Paris, FR München, DE Tokyo, JP Seoul, KR Warszawa, PL see more	Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more
Employees	Employees 75,883	Employees 5,8004% increase	Employees 15,1068% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 21.2 b	Valuation ($) 102.2 b
Financial
Revenue (est.)	Revenue (est.) $56.7b (FY, 2025)	Revenue (est.) $1.9b (FY, 2025)	Revenue (est.) $14.3b (FY, 2025)
Cost of goods	Cost of goods $8.4b (FY, 2025)	Cost of goods $868m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $49.8b (FY, 2025)	Gross profit $1.1b (FY, 2025)	Gross profit N/A
Net income	Net income $14b (FY, 2025)	Net income ($2.8b) (FY, 2025)	Net income $4.5b (FY, 2025)
Operating ⚠
Patents (US)	Patents (US) N/A	Patents (US) 170 (FY, 2021)	Patents (US) 31 (FY, 2020)
Funding
Total funding raised	Total funding raised $ 6.5m	Total funding raised $ 1.8b	Total funding raised $ 53.9m